Literature DB >> 14611671

Roles of luteinizing hormone/chorionic gonadotropin receptor in anchorage-dependent and -independent growth in human ovarian surface epithelial cell lines.

Hironori Tashiro1, Hidetaka Katabuchi, Monjura Begum, Xiaoguang Li, Makoto Nitta, Hideyuki Ohtake, Hitoshi Okamura.   

Abstract

Epithelial ovarian carcinomas are thought to arise from cells of ovarian surface epithelium (OSE) covering the free surface of the human ovary. Two immortalized human cell lines, OSE2a (non-tumorigenic) and OSE2b-2 (tumorigenic), were previously established from normal OSE cells of a reproductive-age patient. In the present study, we found that expression of luteinizing hormone (LH)/chorionic gonadotropin (CG) receptor (LH/CGR) is present in OSE2a cells and absent in OSE2b-2 cells. In OSE2a cells, a low concentration (10(3) mIU/ml) of CG enhanced anchorage-dependent growth via up-regulation of insulin-like growth factor-1 (IGF1), whereas a high concentration (10(5) mIU/ml) of CG induced anchorage-independent growth and down-regulation of IGF1 expression. To investigate involvement of other genes in LH/CGR-related tumorigenicity, we compared cDNA expression arrays of OSE2a and OSE2b-2 cells, and found that the following genes had lower expression in OSE2b-2 than in OSE2a: integrin beta 1, intercellular adhesion molecule-1 (ICAM1), and Waf1/Cip1. Subsequent semiquantitative reverse transcription polymerase chain reaction using OSE2a cells showed that expression of integrin beta 1 was down-regulated by a high concentration (10(5) mIU/ml) of CG. These results suggest that LH/CGR affects anchorage-dependent and -independent growth by mediating up- and down-regulation of IGF1 and integrin beta 1. Repetitive and excessive activation of LH/CGR may cause genetic alteration of its signal transduction pathway, resulting in stimulation of growth of OSE cells, initiation of ovarian carcinogenesis, and cancer progression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14611671     DOI: 10.1111/j.1349-7006.2003.tb01384.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  6 in total

1.  Down-regulation of ARID1A is sufficient to initiate neoplastic transformation along with epigenetic reprogramming in non-tumorigenic endometriotic cells.

Authors:  Ranjani Lakshminarasimhan; Claudia Andreu-Vieyra; Kate Lawrenson; Christopher E Duymich; Simon A Gayther; Gangning Liang; Peter A Jones
Journal:  Cancer Lett       Date:  2017-05-06       Impact factor: 8.679

Review 2.  Microenvironment and pathogenesis of epithelial ovarian cancer.

Authors:  Antonio F Saad; Wei Hu; Anil K Sood
Journal:  Horm Cancer       Date:  2010-12       Impact factor: 3.869

3.  Establishment of an immortalised human ovarian surface epithelial cell line without chromosomal instability.

Authors:  T Maeda; H Tashiro; H Katabuchi; M Begum; H Ohtake; T Kiyono; H Okamura
Journal:  Br J Cancer       Date:  2005-07-11       Impact factor: 7.640

4.  Expression of the luteinizing hormone receptor (LHR) in ovarian cancer.

Authors:  Shigang Xiong; Paulette Mhawech-Fauceglia; Denice Tsao-Wei; Lynda Roman; Rajesh K Gaur; Alan L Epstein; Jacek Pinski
Journal:  BMC Cancer       Date:  2019-11-15       Impact factor: 4.430

5.  E-cadherin expression and bromodeoxyuridine incorporation during development of ovarian inclusion cysts in age-matched breeder and incessantly ovulated CD-1 mice.

Authors:  Jean S Fleming; H James McQuillan; Melanie J Millier; Clare R Beaugié; Vicki Livingstone
Journal:  Reprod Biol Endocrinol       Date:  2007-04-11       Impact factor: 5.211

6.  Insulin and insulin-like growth factor signaling increases proliferation and hyperplasia of the ovarian surface epithelium and decreases follicular integrity through upregulation of the PI3-kinase pathway.

Authors:  Shelby M King; Dimple A Modi; Sharon L Eddie; Joanna E Burdette
Journal:  J Ovarian Res       Date:  2013-02-07       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.